280 results on '"Zhou, Yadi"'
Search Results
2. Optimization of pretreatment and enzymatic hydrolysis coupled with ultrasonication for the production of xylooligosaccharides from corn cob
3. CUL4B functions as a tumor suppressor in KRAS-driven lung tumors by inhibiting the recruitment of myeloid-derived suppressor cells
4. Enhancing safe and effective treatment of carbapenem-resistant Klebsiella pneumoniae with polymyxin B-loaded dendritic nanoparticles
5. Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer’s disease
6. GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity
7. Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer’s disease
8. A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets
9. Repurpose Open Data to Discover Therapeutics for COVID-19 using Deep Learning
10. Abstract 12374: Machine Learning-Based Evaluation of Elevated Left Ventricular End-Diastolic Pressure
11. Alzheimer's disease drug development pipeline: 2024
12. Author Correction: Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer’s disease
13. Galaxy morphology prediction using capsule networks
14. Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation
15. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
16. Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer’s disease
17. Network-Based Metabolomic and Transcriptomic Analyses Identify Impaired Bcaa Catabolism Associated with Chemotherapy-Induced Heart Failure
18. Abstract 11723: Defects in the Branch-Chain Amino Acid Pathway is Associated With Doxorubicin-Induced Cardiotoxicity and Preventable With a BCKDK Inhibitor or Metformin
19. Artificial intelligence in COVID-19 drug repurposing
20. Comprehensive characterization of protein–protein interactions perturbed by disease mutations
21. Widespread transposable element dysregulation in human brains with Alzheimer’s disease
22. CNSC-15. MITOCHONDRIA TRANSFER VIA GLIOMA-ASTROCYTE NETWORK MICROTUBES REPROGRAMS TUMOR CELLS FOR ENHANCED TUMORIGENICITY
23. Preparation and Improvement of Physicochemical and Functional Properties of Dietary Fiber from Corn Cob Fermented by Aspergillus niger
24. My personal mutanome: a computational genomic medicine platform for searching network perturbing alleles linking genotype to phenotype
25. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer’s drug discovery
26. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
27. Multimodal single-cell omics analysis identifies epithelium–immune cell interactions and immune vulnerability associated with sex differences in COVID-19
28. γ-aminobutyric acid drives glioblastoma in females in an immune-dependent manner
29. 3D structural human interactome reveals proteome-wide perturbations by disease mutations
30. Optimization of pretreatment and enzymatic hydrolysis coupled with ultrasonication for the production of xylooligosaccharides from corn cob
31. Data from Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
32. Supplementary Table 1 from Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
33. Supplementary Figures from Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
34. Alzheimer's disease drug development pipeline: 2023
35. Multi-PMSM adjacent cross-coupling iterative learning synchronisation control
36. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
37. Cardiac risk stratification in cancer patients: A longitudinal patient-patient network analysis
38. Integrative proteomics and phosphoproteomics in pulmonary arterial hypertension
39. A Network‐based Deep Learning Framework Translates GWAS and Multi‐Omics Findings to Pathobiology and Drug Repurposing for Alzheimer’s Disease
40. Network medicine‐based multimodal omics analytic framework identifies immunometabolism endophenotypes underlying sex difference of Alzheimer’s disease
41. Sildenafil (Viagra) is a candidate drug for Alzheimer’s disease
42. The Alzheimer’s Cell Atlas (TACA): A single‐cell type transcriptomics and network pathobiology map for target identification and drug repurposing in Alzheimer’s disease and related dementia
43. Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer’s disease
44. A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets
45. Comprehensive characterization of multi-omic landscapes between gut-microbiota metabolites and the G-protein-coupled receptors in Alzheimer’s disease
46. A comprehensive SARS-CoV-2-human protein-protein interactome network identifies pathobiology and host-targeting therapies for COVID-19
47. Peripheral sTREM2-Related Inflammatory Activity Alterations in Early-Stage Alzheimer’s Disease
48. A comprehensive SARS-CoV-2-human protein-protein interactome network reveals novel pathobiology and host-targeting therapies for COVID-19
49. PlantNexus: A Gene Co-expression Network Database and Visualization Tool for Barley and Sorghum
50. Aging‐related cell type‐specific pathophysiologic immune responses that exacerbate disease severity in aged COVID‐19 patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.